Michael Niehaus JRT. Electromagnetic interference in patients with implanted pacemakers or cardioverter-defibrillators. Heart. 2001;86:246–8.
Google Scholar
Douglas J, Quint M. ndications for emergent MRI of the central nervous system. JAMA. 2000;283:853–5.
Article
Google Scholar
Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol. 2005;28:326–8.
Article
Google Scholar
Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H, Weiss RG, Berger RD, Bluemke DA, Halperin HR. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation. 2006;114:1277–84.
Article
Google Scholar
Nazarian S, Halperin HR. How to perform magnetic resonance imaging on patients with implantable cardiac arrhythmia devices. Heart Rhythm. 2009;6:138–43.
Article
Google Scholar
Yoo S, Lee KH, Lee HJ, Ha K, Lim C, Chin HJ, Yun J, Cho EY, Chung E, Baek RM, Chung CY, Wee WR, Lee CH, Lee HS, Byeon NS, Hwang H. Seoul National University Bundang Hospital’s Electronic System for Total Care. Healthc Inform Res. 2012;18:145–52.
Article
Google Scholar
Yoo S, Hwang H, Jheon S. Hospital information systems: experience at the fully digitized Seoul National University Bundang Hospital. J Thorac Dis. 2016;8:S637–41.
Article
Google Scholar
Shellock FG, Woods TO, Crues JV 3rd. MR labeling information for implants and devices: explanation of terminology. Radiology. 2009;253:26–30.
Article
Google Scholar
Sutton R, Kanal E, Wilkoff BL, Bello D, Luechinger R, Jenniskens I, Hull M, Sommer T. Safety of magnetic resonance imaging of patients with a new Medtronic EnRhythm MRI SureScan pacing system: clinical study design. Trials. 2008;9:68.
Article
Google Scholar
Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, Pavri BB, Kurtz SM. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. J Am Coll Cardiol. 2012;60:1540–5.
Article
Google Scholar
Nazarian S, Reynolds M, Ryan M, Hunter T, Wolff S, Mollenkopf S, Turakhia M. Estimating the likelihood of MRI in patients after ICD implantation: a 10-year prediction model. J Am Coll Cardiol. 2015;65:1090.
Article
Google Scholar
The Task Force on Cardiac Pacing, Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association, Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Rev Esp Cardiol (Engl Ed). 2014;67:58.
Google Scholar
Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol. 2004;43:1315–24.
Article
Google Scholar
Sommer T, Naehle CP, Yang A, Zeijlemaker V, Hackenbroch M, Schmiedel A, Meyer C, Strach K, Skowasch D, Vahlhaus C, Litt H, Schild H. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation. 2006;114:1285–92.
Article
Google Scholar
Russo RJ, Costa HS, Silva PD, Anderson JL, Arshad A, Biederman RW, Boyle NG, Frabizzio JV, Birgersdotter-Green U, Higgins SL, Lampert R, Machado CE, Martin ET, Rivard AL, Rubenstein JC, Schaerf RH, Schwartz JD, Shah DJ, Tomassoni GF, Tominaga GT, Tonkin AE, Uretsky S, Wolff SD. Assessing the risks associated with MRI in patients with a pacemaker or defibrillator. N Engl J Med. 2017;376:755–64.
Article
Google Scholar
Roguin A, Zviman MM, Meininger GR, Rodrigues ER, Dickfeld TM, Bluemke DA, Lardo A, Berger RD, Calkins H, Halperin HR. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation. 2004;110:475–82.
Article
Google Scholar
Roguin A. Magnetic resonance imaging in patients with implantable cardioverter-defibrillators and pacemakers. J Am Coll Cardiol. 2009;54:556–7.
Article
Google Scholar
Han D, Kang SH, Cho Y, Oh IY. Experiences of magnetic resonance imaging scanning in patients with pacemakers or implantable cardioverter-defibrillators. Korean J Intern Med. 2018;34:99.
Article
Google Scholar
Forleo GB, Santini L, Della Rocca DG, Romano V, Papavasileiou LP, Magliano G, Sgueglia M, Romeo F. Safety and efficacy of a new magnetic resonance imaging-compatible pacing system: early results of a prospective comparison with conventional dual-chamber implant outcomes. Heart Rhythm. 2010;7:750–4.
Article
Google Scholar
Gold MR, Sommer T, Schwitter J, Al Fagih A, Albert T, Merkely B, Peterson M, Ciuffo A, Lee S, Landborg L, Cerkvenik J, Kanal E, Evera MRISI. Full-body MRI in patients with an implantable cardioverter-defibrillator: primary results of a randomized study. J Am Coll Cardiol. 2015;65:2581–8.
Article
Google Scholar
Shinbane JS, Colletti PM, Shellock FG. Magnetic resonance imaging in patients with cardiac pacemakers: era of “MR Conditional” designs. J Cardiovasc Magn Reson. 2011;13:63.
Article
Google Scholar
Verma A, Ha AC, Dennie C, Essebag V, Exner DV, Khan N, Lane C, Leipsic J, Philippon F, Sampaio M, Schieda N, Seifer C, Berthiaume A, Campbell D, Chakraborty S. Canadian Heart Rhythm Society and Canadian Association of Radiologists consensus statement on magnetic resonance imaging with cardiac implantable electronic devices. Can J Cardiol. 2014;30:1131–41.
Article
Google Scholar